Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Establish the Caring Model of Children With Chronic Kidney Disease and End-stage Renal Disease: To Set up Childhood Glomerular Filtration Rate (GFR) Formula in Taiwan

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2010 by China Medical University Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01250626
First received: November 29, 2010
Last updated: November 30, 2010
Last verified: August 2010
  Purpose
Inulin's usefulness as a diagnostic agent is based on the method of its elimination from the body. Inulin is biologically inert, unbound by plasma proteins, freely filtered at the glomerulus, and is neither reabsorbed, metabolized nor secreted by the kidneys. It is excreted almost entirely by glomerular filtration. Inulin clearance is considered to be identical to glomerular filtration rate (GFR).

Condition Phase
Chronic Kidney Disease
End-Stage Renal Disease
Phase 0

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by China Medical University Hospital:

Enrollment: 80
Study Start Date: August 2010
Groups/Cohorts
a single-group study
Pediatric OPD, age < 18 y/o.

  Eligibility

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pediatric OPD, age < 18 y/o.
Criteria
  1. Main inclusion criteria: Pediatric OPD, age < 18 y/o.
  2. Main exclusion criteria: Acute renal failure, edema, muscular dystrophy, pleural effusion, ascites, malnutrition, neurogenic bladder, heart failure and ketoacidosis. And taken cimetidine or trimethoprim, and accepted renal replacement therapy.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Ching-Yuang Lin, M.D.,PhD., China Medical University
ClinicalTrials.gov Identifier: NCT01250626     History of Changes
Other Study ID Numbers: DMR99-IRB-139 
Study First Received: November 29, 2010
Last Updated: November 30, 2010
Health Authority: Taiwan: Department of Health

Keywords provided by China Medical University Hospital:
Inulin
childhood GFR formula

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency

ClinicalTrials.gov processed this record on December 02, 2016